StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Stock analysts at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued on Sunday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.68 on Friday. The firm has a market capitalization of $20.45 million, a P/E ratio of -1.26 and a beta of 1.98. The stock has a 50-day simple moving average of $0.66 and a two-hundred day simple moving average of $0.87. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.34.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.